US Companies
Every US company filing with the SEC, with its market value, valuation and one-year change.
Market value = latest close × shares outstanding on the newest 10-K or 10-Q cover, each share class at its own price.
P/E and 1-year change are calculated; revenue is the latest annual report as filed. Weight: share of the S&P 500 fund (SPY).
Regeneron Pharmaceuticals, Inc.
Latest values as text and table
Regeneron Pharmaceuticals, Inc.
Everything Plover Analytics holds for Regeneron Pharmaceuticals, Inc. (REGN), SEC number 872589: executive pay, financial statements, annual report text, insider trades, holders, results days, press releases, prices and shares outstanding. Source: SEC EDGAR.